We developed an automated homogeneous immunoassay, based on immune lysis of dinitrophenyl (DNP)-labeled liposomes, for measuring total complement activity. Liposome lysis caused by complement activity was detected spectrophotometrically from entrapped glucose-6-phosphate dehydrogenase activity. Complement activity in human sera was quantified by comparison with a calibration curve. For ease of application to fully automated routine clinical analyzers, we adopted a two-reagent system, one reagent containing a homogeneous population of small DNP-labeled liposomes and one containing antibody/substrate. This system required calibration only once a week. Within-run and between-run CVs were 0.4-1.3% (n = 10) and 1.8-4.7% (n = 10), respectively. Serum results were linear upon dilution (with saline) over a twofold range. Bilirubin, hemoglobin, Intrafat®, and serum proteins such as rheumatoid factor, M protein, IgG, and IgA did not affect the assay results. The results (y) correlated well with those from a hemolytic complement activity test (x): y = 1.05x - 1.14, r = 0.92, on 66 samples in the range <10->50kU/L. This method should therefore be of great use for the determination of complement activity.
CITATION STYLE
Yamamoto, S., Kubotsu, K., Kida, M., Kondo, K., Matsuura, S., Uchiyama, S., … Kanno, T. (1995). Automated homogeneous liposome-based assay system for total complement activity. Clinical Chemistry, 41(4), 586–590. https://doi.org/10.1093/clinchem/41.4.586
Mendeley helps you to discover research relevant for your work.